ReviewCancer drug resistance (Alhambra, Calif.)2025

Disrupting resistance: novel therapeutic approaches to combat multidrug resistance in fusion-negative rhabdomyosarcoma.

Silvia Codenotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.